Newsroom
In The Headlines
Tan, J.Y. et al.
Meta-analysis of ustekinumab trials in psoriasis shows significant improvement over placebo. J Dermatol Treatment. 2011, 22:323.
View AbstractMeta-analysis of ustekinumab trials in psoriasis shows significant improvement over placebo. J Dermatol Treatment. 2011, 22:323.
Marrakchi S et al.
A Psoriasis Gene Emerges: IL-36-Receptor Antagonist Deficiency Causes Generalized Pustular Psoriasis. N Engl J Med. 2011. Aug 18; 365:620.
View AbstractA Psoriasis Gene Emerges: IL-36-Receptor Antagonist Deficiency Causes Generalized Pustular Psoriasis. N Engl J Med. 2011. Aug 18; 365:620.
Huber, A.M. et al.
Treatment consensus published for moderate juvenile dermatomyositis. Arthr Care Res. 2011, 63(11), Advance publication).
View AbstractTreatment consensus published for moderate juvenile dermatomyositis. Arthr Care Res. 2011, 63(11), Advance publication).
Schaarschmidt, M-L. et al.
Treatment location most important in ranking of patient preferences for psoriasis treatments. Arch Dermatol. 2011, 147(11):1285.
View AbstractTreatment location most important in ranking of patient preferences for psoriasis treatments. Arch Dermatol. 2011, 147(11):1285.
Otten MH et al.
Factors associated with treatment response to etanercept in juvenile arthritis. JAMA 2011 Dec 7; 306:2340.
View AbstractFactors associated with treatment response to etanercept in juvenile arthritis. JAMA 2011 Dec 7; 306:2340.
Ahlehoff O et al.
Psoriasis and risk of atrial fibrillation and ischaemis stroke: A Danish Nationwide Cohort Study. Eur Heart J 2011. Aug 12; [e-pub ahead of print].
View AbstractPsoriasis and risk of atrial fibrillation and ischaemis stroke: A Danish Nationwide Cohort Study. Eur Heart J 2011. Aug 12; [e-pub ahead of print].
Balato, N. et al.
Psoriasis may confer protection against melanocytic progression to nevi. Br J Dermatol 2011, 164: 1262.
View AbstractPsoriasis may confer protection against melanocytic progression to nevi. Br J Dermatol 2011, 164: 1262.
Marrakchi S et al.
Interluekin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011, Aug 18; 365:620.
View AbstractInterluekin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011, Aug 18; 365:620.
November 2011
Grijalva CG et al.
Initiation of tumor necrosis factor-a antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 2011, Nov 6.
View AbstractInitiation of tumor necrosis factor-a antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 2011, Nov 6.
Dixon W and Felson DT.
Is anti-TNF therapy safer than previously thought? JAMA 2011, Nov 6. [e-pub ahead of print]
View AbstractIs anti-TNF therapy safer than previously thought? JAMA 2011, Nov 6. [e-pub ahead of print]
Quintard, B. et al.
QualiPso questionnaire found to be valid to assess HRQoL in patients with psoriasis Acta Derm Venereol 2011, 91: 660.
View AbstractQualiPso questionnaire found to be valid to assess HRQoL in patients with psoriasis Acta Derm Venereol 2011, 91: 660.
Xu, L. et al.
Deletion of LCE3C_LCE3B gene associated with psoriasis in northern Chinese patients. BR J Dernatol 2011, 165: 882.
View AbstractDeletion of LCE3C_LCE3B gene associated with psoriasis in northern Chinese patients. BR J Dernatol 2011, 165: 882.
October 2011
Mehta NN et al.
Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011 Aug; 124:775.
View AbstractAttributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011 Aug; 124:775.
Journal Watch Dermatology
Risk for Nonmelanoma skin Cancer Appears Higher in Tumor Necrosis Factor Antagonist Recipients
View AbstractRisk for Nonmelanoma skin Cancer Appears Higher in Tumor Necrosis Factor Antagonist Recipients
Reich K et al.
52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med 2011 Oct 27; 365:1586.
View Abstract52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med 2011 Oct 27; 365:1586.
September 2011
Ryan C et al.
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials. JAMA 2011 Aug 24/31; 306:864.
View AbstractAssociation between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials. JAMA 2011 Aug 24/31; 306:864.
Prizment, A.E. et al.
Association between psoriasis and increased cancer incidence. Cancer Causes Control. 2011, 22: 1003.
View AbstractAssociation between psoriasis and increased cancer incidence. Cancer Causes Control. 2011, 22: 1003.
FDA MedWatch Alert
FDA Adds Listeria, Leionella to Boxed Warning on TNF-alpha Blockers
View AbstractFDA Adds Listeria, Leionella to Boxed Warning on TNF-alpha Blockers
August 2011
Pavlovsky, M. et al.
Narrowband UVB: Efficacy and safety in pediatric psoriasis or atopic dermatitis. JEADV 2011, 25: 727.
View AbstractNarrowband UVB: Efficacy and safety in pediatric psoriasis or atopic dermatitis. JEADV 2011, 25: 727.
Eyerich S et al.
Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011 Jul 21; 365:231.
View AbstractMutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011 Jul 21; 365:231.
Komano Y et al.
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. J Rheumatol 2011 Jul; 38:1258.
View AbstractIncidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. J Rheumatol 2011 Jul; 38:1258.
